Ronald C. Renaud JR - Insider Trading & Ownership

Entity
Individual
Location
C/O Idenix Pharmaceuticals, Inc., 60 Hampshire Street, Cambridge, Massachusetts
Summary
The estimated net worth of Ronald C. Renaud JR is at least $22.3 M dollars as of January 23, 2024. Ronald C. Renaud JR is the President & CEO, Director of Cerevel Therapeutics Holdings, Inc. and owns shares of Cerevel Therapeutics Holdings, Inc. (CERE) stock worth about $22.3 M. Ronald C. Renaud JR is the Director of Atara Biotherapeutics, Inc. and owns shares of Atara Biotherapeutics, Inc. (ATRA) stock worth about $12.3 K.
All Insider Reports
All Insider Reports

Ownership of Ronald C. Renaud JR

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
CERE Cerevel Therapeutics Holdings, Inc. President & CEO, Director $22.3 M +$2.01 M +9.89% Jan 19, 2024
ATRA Atara Biotherapeutics, Inc. Director $12.3 K Jun 23, 2022
IKNA Ikena Oncology, Inc. Director Jun 9, 2022
TBIO Translate Bio, Inc. Chief Executive Officer, Director Sep 14, 2021

Insider Transactions Reported by Ronald C. Renaud JR:

Sym Company Class Transaction % Value $ Price $ Shares Shares After Date Ownership